353 related articles for article (PubMed ID: 16103149)
1. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
Schröfelbauer B; Yu Q; Zeitlin SG; Landau NR
J Virol; 2005 Sep; 79(17):10978-87. PubMed ID: 16103149
[TBL] [Abstract][Full Text] [Related]
2. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
Kaiser SM; Emerman M
J Virol; 2006 Jan; 80(2):875-82. PubMed ID: 16378989
[TBL] [Abstract][Full Text] [Related]
3. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.
Mansky LM; Preveral S; Selig L; Benarous R; Benichou S
J Virol; 2000 Aug; 74(15):7039-47. PubMed ID: 10888643
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.
Bouhamdan M; Benichou S; Rey F; Navarro JM; Agostini I; Spire B; Camonis J; Slupphaug G; Vigne R; Benarous R; Sire J
J Virol; 1996 Feb; 70(2):697-704. PubMed ID: 8551605
[TBL] [Abstract][Full Text] [Related]
6. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
Yang B; Chen K; Zhang C; Huang S; Zhang H
J Biol Chem; 2007 Apr; 282(16):11667-75. PubMed ID: 17272283
[TBL] [Abstract][Full Text] [Related]
7. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest.
Selig L; Benichou S; Rogel ME; Wu LI; Vodicka MA; Sire J; Benarous R; Emerman M
J Virol; 1997 Jun; 71(6):4842-6. PubMed ID: 9151883
[TBL] [Abstract][Full Text] [Related]
8. DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism.
Willetts KE; Rey F; Agostini I; Navarro JM; Baudat Y; Vigne R; Sire J
J Virol; 1999 Feb; 73(2):1682-8. PubMed ID: 9882380
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.
Argyris EG; Pomerantz RJ
Trends Microbiol; 2004 Apr; 12(4):145-8. PubMed ID: 15116720
[No Abstract] [Full Text] [Related]
10. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
[TBL] [Abstract][Full Text] [Related]
12. Repair of APOBEC3G-Mutated Retroviral DNA
Salas-Briceno K; Ross SR
J Virol; 2021 Oct; 95(22):e0124421. PubMed ID: 34468176
[TBL] [Abstract][Full Text] [Related]
13. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM; Gaddis NC; Malim MH
Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
Guo F; Cen S; Niu M; Saadatmand J; Kleiman L
J Virol; 2006 Dec; 80(23):11710-22. PubMed ID: 16971427
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.
Hrecka K; Hao C; Shun MC; Kaur S; Swanson SK; Florens L; Washburn MP; Skowronski J
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):E3921-30. PubMed ID: 27335459
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.
Schröfelbauer B; Hakata Y; Landau NR
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4130-5. PubMed ID: 17360488
[TBL] [Abstract][Full Text] [Related]
17. Roles of uracil-DNA glycosylase and dUTPase in virus replication.
Chen R; Wang H; Mansky LM
J Gen Virol; 2002 Oct; 83(Pt 10):2339-2345. PubMed ID: 12237414
[TBL] [Abstract][Full Text] [Related]
18. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
19. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
